![tirzepatide blindness adolescent obesity trial once weekly for the treatment of in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, Zepbound Blindness Lawsuit [2026 Update]](https://www.thebrighterside.news/uploads/2025/04/Screenshot-2025-04-12-100117.png)
![tirzepatide blindness adolescent obesity trial once weekly for the treatment of in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, Zepbound Blindness Lawsuit [2026 Update]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8de6/12316913/ec090ef98257/43856_2025_1066_Fig3_HTML.jpg)
![tirzepatide blindness adolescent obesity trial once weekly for the treatment of in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, Zepbound Blindness Lawsuit [2026 Update]](https://cdn.prod.website-files.com/60e33881a9643382c407b823/67b7e450f9483cd4398eaafd_Ozempic_blindess-1240x640-Fay_Banner.png)
![tirzepatide blindness adolescent obesity trial once weekly for the treatment of in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, Zepbound Blindness Lawsuit [2026 Update]](https://substackcdn.com/image/fetch/$s_!3VUS!,w_1200,h_675,c_fill,f_jpg,q_auto:good,fl_progressive:steep,g_auto/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fbbb4e46a-97af-430f-a734-10dd1d8f0119_1536x1024.heic)
tirzepatide blindness
Shipping Estimate
tirzepatide blindness adolescent obesity trial once weekly for the treatment of in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, Zepbound Blindness Lawsuit [2026 Update]
EUR26.18
EUR72.18
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
![tirzepatide blindness adolescent obesity trial once weekly for the treatment of in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, Zepbound Blindness Lawsuit [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/09/can-zepbound-make-you-blind.webp)
![tirzepatide blindness adolescent obesity trial once weekly for the treatment of in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, Zepbound Blindness Lawsuit [2026 Update]](https://www.verywellhealth.com/thmb/wbDsUBarUmAhi5OuJJuJfM4xj_4=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
![tirzepatide blindness adolescent obesity trial once weekly for the treatment of in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, Zepbound Blindness Lawsuit [2026 Update]](https://cdn.prod.website-files.com/62aec59ac7c1e4f6f1719e4a/690a2d36b332194c57a2de60_xAhsnaAnIBRu6D5ZWoO8u2baMPE-3qBz_L0uGBnCICU.png)
![tirzepatide blindness adolescent obesity trial once weekly for the treatment of in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, Zepbound Blindness Lawsuit [2026 Update]](https://media.post.rvohealth.io/wp-content/uploads/sites/3/2025/02/Ozempic-vision-Stocksy_txp99efc428S05400_Medium_173681-Facebook.jpg)
